[go: up one dir, main page]

AR009105A1 - DERIVATIVES OF N- (BENZOTIAZOL-2-IL) PIPERIDINE-1-ETHANAMINE, ITS PREPARATION AND APPLICATION IN THERAPEUTICS - Google Patents

DERIVATIVES OF N- (BENZOTIAZOL-2-IL) PIPERIDINE-1-ETHANAMINE, ITS PREPARATION AND APPLICATION IN THERAPEUTICS

Info

Publication number
AR009105A1
AR009105A1 ARP970104493A ARP970104493A AR009105A1 AR 009105 A1 AR009105 A1 AR 009105A1 AR P970104493 A ARP970104493 A AR P970104493A AR P970104493 A ARP970104493 A AR P970104493A AR 009105 A1 AR009105 A1 AR 009105A1
Authority
AR
Argentina
Prior art keywords
therapeutics
benzotiazol
ethanamine
piperidine
derivatives
Prior art date
Application number
ARP970104493A
Other languages
Spanish (es)
Original Assignee
Wicke K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wicke K filed Critical Wicke K
Publication of AR009105A1 publication Critical patent/AR009105A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Compuestos que responden a la formula general (I) en la cual n representa el numero 0, 1, 2 o 3, R1, representa un átomo de hidrogeno o de halogeno o ungrupo metilo o metoxi, R2 representa un átomo de hidrogeno o un grupo metilo y R3 representa unátomo de hidrogeno o uno o dos átomos de halogeno. Aplicacionen terapéutica.Compounds according to the general formula (I) in which n represents the number 0, 1, 2 or 3, R1 represents a hydrogen or halogen atom or a methyl or methoxy group, R2 represents a hydrogen atom or a group methyl and R3 represents a hydrogen atom or one or two halogen atoms. Apply therapeutics.

ARP970104493A 1996-10-01 1997-09-30 DERIVATIVES OF N- (BENZOTIAZOL-2-IL) PIPERIDINE-1-ETHANAMINE, ITS PREPARATION AND APPLICATION IN THERAPEUTICS AR009105A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9611925A FR2753970B1 (en) 1996-10-01 1996-10-01 N- (BENZOTHIAZOL-2-YL) PIPERIDINE-1-ETHANAMINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

Publications (1)

Publication Number Publication Date
AR009105A1 true AR009105A1 (en) 2000-03-08

Family

ID=9496217

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970104493A AR009105A1 (en) 1996-10-01 1997-09-30 DERIVATIVES OF N- (BENZOTIAZOL-2-IL) PIPERIDINE-1-ETHANAMINE, ITS PREPARATION AND APPLICATION IN THERAPEUTICS

Country Status (23)

Country Link
EP (1) EP0929550A1 (en)
JP (1) JP2001501217A (en)
KR (1) KR20000048767A (en)
CN (1) CN1230959A (en)
AR (1) AR009105A1 (en)
AU (1) AU722147B2 (en)
BG (1) BG103271A (en)
BR (1) BR9711842A (en)
CA (1) CA2266510A1 (en)
CO (1) CO4650030A1 (en)
CZ (1) CZ112699A3 (en)
EE (1) EE9900135A (en)
FR (1) FR2753970B1 (en)
HU (1) HUP9904091A3 (en)
IL (1) IL128902A (en)
NO (1) NO991581L (en)
NZ (1) NZ334553A (en)
PL (1) PL332648A1 (en)
SK (1) SK42299A3 (en)
TR (1) TR199900634T2 (en)
TW (1) TW438800B (en)
WO (1) WO1998014444A1 (en)
ZA (1) ZA978772B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9725541D0 (en) * 1997-12-02 1998-02-04 Pharmacia & Upjohn Spa Amino-benzothiazole derivatives
US6107313A (en) * 1998-10-02 2000-08-22 Combichem, Inc. Dopamine receptor antagonists
CA2413086C (en) 2000-06-21 2011-06-28 Alexander Alanine Benzothiazole derivatives
US7087761B2 (en) 2003-01-07 2006-08-08 Hoffmann-La Roche Inc. Cyclization process for substituted benzothiazole derivatives
MXPA06004304A (en) * 2003-10-24 2006-06-05 Hoffmann La Roche Ccr3 receptor antagonists.
UA87142C2 (en) 2004-05-24 2009-06-25 Ф.Хоффманн-Ля Рош Аг 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide
JP4633123B2 (en) 2004-11-05 2011-02-16 エフ.ホフマン−ラ ロシュ アーゲー Method for producing isonicotinic acid derivative
BRPI0609719B8 (en) 2005-03-23 2021-05-25 Hoffmann La Roche acetylenyl-pyrazole-pyrimidine derivatives as mgbur2 antagonists
EP1934214B1 (en) 2005-09-27 2010-04-07 F.Hoffmann-La Roche Ag Oxadiazolyl pyrazolo-pyrimidines as mglur2 antagonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1260474A (en) * 1984-12-03 1989-09-26 Raymond A. Stokbroekx Benzoxazol- and benzothiazolamine derivatives
KR930005004B1 (en) * 1985-04-15 1993-06-11 쟈안센 파아마슈우티카 엔. 부이. Process for preparing substituted N-[(4-piperidinyl) alkyl] bicyclic condensed oxazolamines and thiazoleamines

Also Published As

Publication number Publication date
NO991581D0 (en) 1999-03-30
CO4650030A1 (en) 1998-09-03
AU4463897A (en) 1998-04-24
CA2266510A1 (en) 1998-04-09
AU722147B2 (en) 2000-07-20
TW438800B (en) 2001-06-07
CZ112699A3 (en) 1999-06-16
IL128902A (en) 2001-07-24
EE9900135A (en) 1999-12-15
KR20000048767A (en) 2000-07-25
BG103271A (en) 2000-05-31
IL128902A0 (en) 2000-02-17
HUP9904091A2 (en) 2000-05-28
FR2753970A1 (en) 1998-04-03
HUP9904091A3 (en) 2000-07-28
PL332648A1 (en) 1999-09-27
NZ334553A (en) 2000-11-24
SK42299A3 (en) 1999-12-10
WO1998014444A1 (en) 1998-04-09
NO991581L (en) 1999-06-01
BR9711842A (en) 1999-08-24
EP0929550A1 (en) 1999-07-21
JP2001501217A (en) 2001-01-30
FR2753970B1 (en) 1998-10-30
CN1230959A (en) 1999-10-06
TR199900634T2 (en) 1999-06-21
ZA978772B (en) 1998-03-27

Similar Documents

Publication Publication Date Title
DK1200418T3 (en) Nematodicidal trifluorobutene
MX9301986A (en) DERIVATIVES OF PERHYDROISOINDOL, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
ES2053609T3 (en) DERIVATIVES OF UREA LIPOXIGENASA INHIBITORS.
YU26691A (en) BOROIC ACID ADUCTS RENIUM DIOXIME AND TECHNICIUM-99 m DIOXIME COMPLEX AND MARKING ACCESSORIES WITH TECHNICIUM 99 m AND / OR RENIUM RADIONUCLEID
ES2085876T3 (en) DERIVATIVE OF BIPHENYLMETHANE, ITS USE AND PHARMACOLOGICAL COMPOSITIONS THAT CONTAIN THE SAME.
AR002012A1 (en) A COMPOUND, A PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS IT, ITS USE, METHOD OF THERAPEUTIC TREATMENT, METHOD FOR THE PREPARATION OF THE COMPOUND.
FR2518088B1 (en) NOVEL AMINO ACID DERIVATIVES AND THEIR THERAPEUTIC APPLICATION
ES2195970T3 (en) L-RIBAVIRINA AND USES OF THE SAME.
NO20075066L (en) Pharmaceutical composition containing isoflavones
ATE269312T1 (en) N-(AMIDINOPHENYL)-N'-(NOUN)-3H-2,4-BENZODIAZEPINE-3-ONE DERIVATIVES AS FACTOR XA INHIBITORS
ES2093211T3 (en) DERIVATIVES OF NUCLEOSIDES OF PIRIMIDINE THAT HAVE AN ANTI-TUMOR ACTIVITY, ITS PREPARATION AND USE.
DE69232665D1 (en) NEW 4-ARYLPIPERAZINE AND 4-ARYLPIPERIDINE
DE69202822D1 (en) Silicone modified aqueous coating composition.
TR199701654T1 (en) 4-Fenilaminotiyazol t�revleri.
YU37098A (en) Novel erythromycin derivatives, method for preparing same and use thereof as drugs
DE69625354D1 (en) RELAXIN-LIKE FACTOR AND RELATED METHODS AND USE
CO4700298A1 (en) DERIVATIVES OF 3-PHENYLISOKINOLEIN-1 (2H) -ONE, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS
ES2117976T3 (en) PREPARATION OF N-ACETYL NEURAMINIC DERIVATIVES.
AR009105A1 (en) DERIVATIVES OF N- (BENZOTIAZOL-2-IL) PIPERIDINE-1-ETHANAMINE, ITS PREPARATION AND APPLICATION IN THERAPEUTICS
AR020563A1 (en) TIA-ALQUINOIC COMPOUNDS (POLI) AND THEIR DERIVATIVES, COMPOSITIONS THAT INCLUDE THEM AND THEIR USE
FR2631625B1 (en) PHENYL-6 DERIVATIVES PIPERAZINYLALKYL-3 1H, 3H-PYRIMIDINEDIONE-2,4, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2847899B1 (en) Indole-3-carboxamide derivatives, preparation and application in therapy
MX9204179A (en) DERIVATIVES OF IMIDAZO (2,1-B) BENZOTIAZOLA-3-ACETAMIDA, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS.
ES2119874T3 (en) NEW DERIVATIVES OF ELIPTICINA, ITS PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
ES2194457T3 (en) PLATINUM COMPLEX, ITS PREPARATION AND THERAPEUTIC APPLICATION.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal